New rapid test could spot COVID and flu in minutes

NCT ID NCT05787444

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study checked how well a new rapid test (LumiraDx) detects COVID-19 and flu A/B from a simple nose swab. Over 1,000 people with symptoms took part at clinics. The test aims to give fast results at the point of care, helping doctors tell these illnesses apart quickly.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

LumiraDx SARS-CoV-2 & Flu A/B test (rapid diagnostic test)

What this could lead to

If successful, this test could provide quick, accurate results for COVID-19 and flu at clinics or pharmacies, helping doctors decide treatment faster.

What could go wrong

This is a completed validation study, not a treatment trial. The test may not be as accurate in real-world use or for asymptomatic people, and it only works within 6 days of symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARS COV-2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 influenza swine influenza

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cullman Clinical Trials

    Cullman, Alabama, 35055, United States